Iodine-based oral rinse - Biomedical Development Corporation

Drug Profile

Iodine-based oral rinse - Biomedical Development Corporation

Alternative Names: Frio mouth rinse; Frio oral rinse; iCLEAN/FRIO; Iocide; Iocide oral rinse

Latest Information Update: 14 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biomedical Development Corporation
  • Developer Biomedical Development Corporation; Foundation Of Collaborative Unique Science; Methodist Healthcare Ministries of South Texas; National Institute of Nursing Research
  • Class Disinfectants; Halogens
  • Mechanism of Action Endotoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Gingivitis
  • Phase I Candidiasis; Periodontitis; Urinary tract infections

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 14 Apr 2016 Phase-II development for Gingivitis, and phase I development for candidiasis, periodontitis and urinary tract infections, are ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top